We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+7.06%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$600M
AUM Growth
+$420M
(+234%)
Cap. Flow
+$429M
Cap. Flow
% of AUM
71.56%
Top 10 Holdings %
Top 10 Hldgs %
7.78%
Holding
1,485
New
912
Increased
233
Reduced
74
Closed
263
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$10.9M |
| 2 |
ORPH
Orphazyme A/S
ORPH
|
+$4.91M |
| 3 |
BLDP
Ballard Power Systems
BLDP
|
+$3.2M |
| 4 |
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
|
+$3.09M |
| 5 |
Insmed
INSM
|
+$2.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NBIS
Nebius Group N.V.
NBIS
|
+$5.11M |
| 2 |
Advanced Micro Devices
AMD
|
+$1.99M |
| 3 |
T-Mobile US
TMUS
|
+$1.77M |
| 4 |
Micron Technology
MU
|
+$1.68M |
| 5 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$1.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.8% |
| 2 | Industrials | 15.11% |
| 3 | Healthcare | 13.87% |
| 4 | Technology | 12.38% |
| 5 | Financials | 11.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
ADMA Biologics
ADMA
$2.22B
| $558K | 0.09% |
+233,425
| New | +$640K |
|
|
ZYXI
327
DELISTED
Zynex
ZYXI
| $558K | 0.09% |
+35,188
| New | +$594K |
|
328
Arrow Electronics
ARW
$10.4B
| $556K | 0.09% |
+7,070
| New | +$522K |
|
329
Carlisle Companies
CSL
$15.4B
| $556K | 0.09% |
+4,547
| New | +$558K |
|
|
JAX
330
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $555K | 0.09% |
+106,825
| New | +$466K |
|
331
Semtech
SMTC
$13B
| $554K | 0.09% |
+10,453
| New | +$588K |
|
332
Vishay Precision Group
VPG
$914M
| $554K | 0.09% |
+21,876
| New | +$542K |
|
|
LSI
333
DELISTED
Life Storage, Inc.
LSI
| $554K | 0.09% |
+7,890
| New | +$535K |
|
334
Star Group
SGU
$423M
| $553K | 0.09% |
56,729
+39,098
| +222% | +$364K |
|
335
Cato Corp
CATO
$66.1M
| $552K | 0.09% |
+70,609
| New | +$554K |
|
336
Syndax Pharmaceuticals
SNDX
$1.82B
| $552K | 0.09% |
+37,420
| New | +$570K |
|
337
JFrog
FROG
$10.8B
| $550K | 0.09% |
+6,500
| New | +$484K |
|
338
Abercrombie & Fitch
ANF
$5B
| $549K | 0.09% |
39,380
+20,194
| +105% | +$236K |
|
|
HARP
339
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $548K | 0.09% |
3,224
+2,069
| +179% | +$298K |
|
|
KBAL
340
DELISTED
Kimball International
KBAL
| $547K | 0.09% |
+51,902
| New | +$578K |
|
|
UFS
341
DELISTED
DOMTAR CORPORATION (New)
UFS
| $547K | 0.09% |
20,826
+6,657
| +47% | +$169K |
|
342
Hancock Whitney
HWC
$6.24B
| $545K | 0.09% |
+28,998
| New | +$568K |
|
343
Ardmore Shipping
ASC
$683M
| $543K | 0.09% |
+152,503
| New | +$597K |
|
344
Landstar System
LSTR
$6.21B
| $543K | 0.09% |
+4,330
| New | +$545K |
|
|
PHAS
345
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $542K | 0.09% |
+154,316
| New | +$622K |
|
|
PRVL
346
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $540K | 0.09% |
+53,018
| New | +$711K |
|
347
Future Fuel
FF
$223M
| $538K | 0.09% |
+47,322
| New | +$591K |
|
348
CarGurus
CARG
$3.47B
| $536K | 0.09% |
+24,795
| New | +$635K |
|
|
CALA
349
DELISTED
Calithera Biosciences, Inc
CALA
| $536K | 0.09% |
7,765
+5,595
| +258% | +$488K |
|
350
Arcus Biosciences
RCUS
$3.64B
| $535K | 0.09% |
31,217
+21,800
| +231% | +$487K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, GSA Capital Partners held 1,485 positions worth $600M, up 234% from $179M the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
GSA Capital Partners deployed $429M of net new capital in Q3 2020, opening 912 new positions and adding to 233 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 130,000 shares worth $10.9M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Nebius Group N.V., an estimated $5.11M trimmed.
- GSA Capital Partners's largest Q3 2020 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 130,000 shares worth $10.9M.
- GSA Capital Partners added most to Michaels Stores, Inc in Q3 2020, an estimated $2.48M increase.
- GSA Capital Partners's biggest Q3 2020 reduction was Nebius Group N.V., cutting an estimated $5.11M.
- GSA Capital Partners fully exited T-Mobile US in Q3 2020, selling an estimated $1.77M.
- GSA Capital Partners's ten largest holdings make up 7.8% of its $600M portfolio in Q3 2020.
- GSA Capital Partners opened 912 new positions and closed 263 in Q3 2020.
- GSA Capital Partners's portfolio value rose 234% quarter-over-quarter to $600M.
Based on GSA Capital Partners's 13F filing for Q3 2020, filed 6 Nov 2020.